Anthony T. Kerigan
Abstract
In Paul Armstrong's review article on fibrinolytic therapy for acute ST-segment elevation myocardial infarction, the fibrinolytic or thrombolytic treatment recommended for the case presented is not completely supported by the evidence cited.[1][1] In the Fibrinolytic Therapy Trialists' study a
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
In Paul Armstrong's review article on fibrinolytic therapy for acute ST-segment elevation myocardial infarction, the fibrinolytic or thrombolytic treatment recommended for the case presented is not completely supported by the evidence cited.[1][1] In the Fibrinolytic Therapy Trialists' study a
Key concepts: Fibrinolytic therapy, Myocardial infarction, Medicine, ST segment, Fibrinolytic agent, Elevation (ballistics), Cardiology, Internal medicine